A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

NCT00109083 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Headaches

Interventions

DRUG: RWJ-333369

Sponsor

SK Life Science, Inc.